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PURPOSE. To determine the composition of extracellular matrix (ECM) proteins secreted
by a conjunctival epithelial cell line and to identify components that aid conjunctival
epithelial cell culture.
METHODS. Human conjunctival epithelial cell line (HCjE-Gi) cells were cultured in serum-
free media and their ECM isolated using ammonium hydroxide. Growth characteristics
were evaluated for fresh HCjE-Gi cells plated onto ECMs obtained from 3- to 28-day
cell cultures. Mass spectrometry was used to characterize the ECM composition over
42 culture days. Cell adhesion and growth on pre-adsorbed fibronectin and α-2-HS-
glycoprotein (α-2-HS-GP) were investigated.
RESULTS. Day 3 ECM provided the best substrate for cell growth compared to ECM
obtained from 5- to 28-day cell cultures. Mass spectrometry identified a predominantly
laminin 332 matrix throughout the time course, with progressive changes to matrix
composition over time: proportional decreases in matrix-bound growth factors and
increases in proteases. Fibronectin and α-2-HS-GP were 5- and 200-fold enriched as
a proportion of the early ECM relative to the late ECM, respectively. Experiments on
these proteins in isolation demonstrated that fibronectin supported rapid cell adhesion,
whereas fibronectin and α-2-HS-GP both supported enhanced cell growth compared to
tissue culture polystyrene.
CONCLUSIONS. These data reveal α-2-HS-GP as a candidate protein to enhance the growth
of conjunctival epithelial cells and raise the possibility of exploiting these findings for
targeted improvement to synthetic tissue engineered conjunctival substrates.
Keywords: ocular surface, conjunctiva, extracellular matrix, tissue engineering, mass
spectrometry
The conjunctiva is an integral component of the ocularsurface system, protecting the eyes from external insults
by acting as a physical and an immunological barrier.1,2
It does so through forming a stratified non-keratinizing
epithelium comprised of epithelial cells and mucosecretory
goblet cells adhered to a basement membrane.3 The conjunc-
tiva contains its own pool of stem cells for epithelial and
goblet cell renewal.2 The epithelial and goblet cells produce
mucins, which act as a second barrier layer and also prevent
desiccation of the epithelium.2,3 Despite the existence of
multiple defense mechanisms, the conjunctiva is prone to
injury and entry of pathogens or damage as a result of
systemic autoimmune diseases.4,5 Subsequent scarring may
lead to anatomical and functional impairment. In severe
cases, the limbus and cornea may also be impaired leading
to loss of vision.6 Importantly, surgical procedures such as
limbal and corneal transplantation fail without prior restora-
tion of the function of the conjunctival epithelia.3,7 The ideal
conjunctival repair is an autograft graft.8 Diseases, however,
often involve both eyes or there is insufficient uninvolved
tissue in the fellow eye for this to be available.9 Although
allogeneic grafts may be an option, this approach carries
the risks of graft rejection, microbial disease transmission,
and immunosuppression, and there are limitations to tissue
availability.10 An attractive alternative, therefore, is the devel-
opment of a functional ex vivo tissue construct that can be
transplanted to restore the anatomical structure and func-
tions of the original tissue.
The success of an ex vivo expanded tissue construct
depends on three factors: the source of cells, the presence of
stem cells, the carrier substrate, and the presence of growth
factors (GFs).11 The substrate provides the initial support for
the cultured cells and the appropriate physical and biologi-
cal cues for growth of cells.12 Moreover, the physical proper-
ties of the substrate facilitates the delivery of cultured cells to
the site of interest and provides a three-dimensional scaffold
for the formation of new tissue.13 A large number of studies
have been carried out to investigate various biological and
synthetic substrates in the search for an optimal substrate
for the ex vivo culture of conjunctival epithelial cells and,
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although substantive advancements have been made, signif-
icant technical challenges still remain.
Test substrates fall into two classes: (1) biological
substrates, such as amniotic membrane and nasal and oral
mucous membranes, and (2) synthetic substrates, such as
poly(ε-caprolactone) and poly(lactic-co-glycolic acid).10,14–17
Biological substrates are attractive cell carrier options, as
they are generally biodegradable and contain biologically
active domains that support various cellular functions.18
However, biological substrates have inferior mechanical
properties, which make them more difficult to handle clin-
ically. Additionally, they may be limited in supply, they
may elicit an immunological reaction in vivo, and, when
taken from a different body location, may retain signals
that drive differentiation of cells down an inappropriate
lineage.18 In contrast, synthetic substrates have a known,
tunable, and consistent composition that can be modified to
suit requirements and benefit from constant ready supply.
However, there are clear disadvantages in terms of lack of
structural similarity to in vivo cellular microenvironments
and non-biologically accurate presentation of the signaling
cues.19
The extracellular matrix (ECM) regulates the growth and
differentiation of cells, thus providing specific biological
and physical cues.12,20 The vast majority of studies driving
development of synthetic carriers have investigated a rela-
tively narrow range of candidate biologically active ECM
molecules and their derived peptides.3,18,21,22 Here, we have
approached the problem from a different angle.We hypothe-
sized that the best substrate for growing conjunctival epithe-
lial cells is likely to be the substrate laid down by healthy
cells themselves. Identifying biologically active components
within a healthy culture of conjunctival cells could provide
a valuable first step toward an improved synthetic substrate
for cell and tissue transplantation purposes. To investi-
gate this, we performed a hypothesis-independent, mass-
spectrometry-based characterization of the composition of
the native ECM of conjunctival cells in culture and used those




Cells from the immortalized human conjunctival epithelial
cell line (HCjE-Gi; kindly donated by Gipson Laboratory at
Schepens Eye Research Institute-Massachusetts Eye and Ear,
Harvard Medical School, Boston, MA, USA) were cultured
and maintained according to published protocol.23 Briefly,
the cells were cultured in keratinocyte serum-free (KSF)
media (Life Technologies, Carlsbad, CA, USA) containing
25-μg/mL bovine pituitary extract and 0.2-ng/mL human
recombinant epidermal growth factor 1-53 (supplied with
media), 0.4-mM calcium chloride (Sigma-Aldrich, St. Louis,
MO, USA), and 1× penicillin–streptomycin (Sigma-Aldrich)
in a humidifying incubator at 37°C with 5% carbon diox-
ide. The cells were maintained in 75-cm2 flasks (Greiner
AG, Kremsmünster, Austria), and fresh media were supplied
three times a week. Cells were used in experiments with
an initial seeding density of 1 × 104 cells/cm2 unless speci-
fied otherwise. At this seeding density, cells progressed from
approximately 10% to 90% confluent through the first 7 days
after seeding (Supplementary Figs. S1A, S1B)
Isolation of the ECM
Ammonium hydroxide (NH4OH) was used to remove the
cells and isolate the underlying ECM.24,25 Culture media were
removed, and the cells were washed three times with PBS
(Thermo Fisher Scientific Oxoid Ltd., Basingstoke, United
Kingdom). The cells were then incubated in 1% NH4OH solu-
tion (Fisher Scientific, Hampton, NH, USA) for 5 minutes at
37°C. The NH4OH solution was removed, and the wells were
washed vigorously with PBS three times to remove cellu-
lar debris, leaving only the deposited ECM. For cell behav-
ioral analyses, fresh HCjE-Gi cells were plated directly onto
the prepared cell-derived ECMs. For mass spectrometry, cell-
derived ECMs were solubilized from the dishes.
Comparison of HCjE-Gi Cell Response to
Cell-Deposited ECMs
HCjE-Gi cells were cultured in 48-well plates (Greiner). On
culture days 3, 5, 7, 14, 21, and 28, the cell-secreted ECM
was isolated. Following thorough PBS washes, fresh HCjE-
Gi cells were seeded onto the cell-deposited ECMs at a
density of 1 × 104 cells/cm2 in KSF culture media. Tissue
culture polystyrene (TCP) incubated with 1% NH4OH solu-
tion and then thoroughly washed with sterile PBS was used
as the control substrate. We then assessed the cell numbers
on the different culture conditions on culture days 1, 3, 5,
and 7 after seeding. The cells were fixed with 100% ice-
cold methanol for 2 minutes, air dried, and stained with
4′,6-diamidino-2-phenylindole (DAPI) (Life Technologies; 5
mg/mL diluted 1:30,000 in PBS) for 5 minutes at room
temperature (RT). Images were acquired with a 10× objec-
tive from five fixed positions of each well, and the number
of nuclei per view was determined. The number of nuclei
per view on cell-secreted ECM was divided by the number of
nuclei of the corresponding view on TCP to obtain ECM:TCP
cell number ratios. All experiments were carried out three
times, with three technical repeats per independent experi-
ment.
Identification and Quantification of HCjE-Gi
Cell-Secreted ECM Proteins by Mass Spectrometry
HCjE-Gi cells were cultured in 48-well plates and maintained
in KSF media for up to 6 weeks. The ECM was isolated using
1% NH4OH from cell cultures on days 1, 7, 14, 28, and 42
after seeding. The samples were dried and stored at –20°C
until all of the samples were collected. The samples were
then thawed, and RapiGest SF (Waters Corporation, Milford,
MA, USA), an anionic surfactant, was used to solubilize the
ECM directly on the dishes for subsequent in-solution tryptic
digestion. RapiGest SF has been demonstrated to be highly
effective for ECM protein solubilization.26,27 First, 285 μL of
0.052% (w/v) RapiGest SF surfactant reconstituted in ammo-
nium bicarbonate (NH4HCO3) (Sigma-Aldrich) was added to
each sample well (final concentration 0.05%). The samples
were incubated with the RapiGest SF solution for 30 minutes
at RT on a plate shaker (VXR basic Vibrax, IKAWerke GmbH,
Staufen, Germany) and then for 10 minutes at 80°C. The
samples were cooled to RT and transferred into 1.7-mL low-
binding tubes (Corning Inc., Corning, NY, USA). To ensure
maximum ECM recovery, each well was rinsed with a further
100 μL of RapiGest SF, and this was transferred to the same
low-binding tubes and the samples gently vortexed. Half
of the protein extract (192.5 μL) was aspirated into new
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low-binding tubes, and 2.5 μL of 60-mM dithiothreitol
(Melford Biolaboratories Ltd, Ipswich, United Kingdom)
reconstituted in 25-mM NH4HCO3 (final concentration of
0.75 mM) was added. The samples were vortexed and incu-
bated at 60°C for 10 minutes. Next, 2.5 μL of 180-mM iodoac-
etamide (Sigma) reconstituted in 25-mM NH4HCO3 (final
concentration of 2.25 mM) was added and incubated for
30 minutes at RT in the dark. Finally, 100-ng/μL trypsin
(Trypsin Gold Mass Spectrometry Grade; Promega, Fitch-
burg, WI, USA) was made by diluting 200-ng/μL stock solu-
tion in 50-mM acetic acid (VWR, Radnor, PA, USA) with an
equal volume of 25-mM NH4HCO3. The samples were incu-
bated at 37°C overnight with 2.5 μL of trypsin.
The following day the samples were mixed with 1 μL of
trifluoroacetic acid (Biosolve Chimie, Dieuze, France). The
samples were incubated at 37°C for 45 minutes and then
centrifuged at 17,200g for 30 minutes. The clarified digests
were transferred to fresh low-binding tubes and the centrifu-
gation step repeated before transfer to total recovery vials
for liquid chromatography tandem mass spectrometry (LC-
MS/MS) analysis. Data-dependent LC-MS/MS analyses were
conducted on a Q Exactive HF Hybrid Quadrupole-Orbitrap
Mass Spectrometer coupled to a Dionex UltiMate 3000 RSLC-
nano Liquid Chromatograph system (Thermo Fisher Scien-
tific, Waltham, MA, USA). Please refer to Supplementary
Methods S1 for further details.
As the total cell number increased over the time course
of the study, the raw data with the number of peptides of
each protein found in each sample were incorporated into
downstream analyses. The raw peptide counts were divided
by the total peptide count for each time point to determine
the proportion of each protein within a sample.
Adhesion and Cell Density of HCjE-Gi Cells on
Pre-Adsorbed Proteins
Solutions containing 0.5- to 10-μg/mL fibronectin from
human plasma (Sigma-Aldrich) and 0.5- to 20-μg/mL α-2-
HS-glycoprotein (α-2-HS-GP) from human plasma (Sigma-
Aldrich) were prepared in PBS. The 96-well plates (Greiner)
were pre-adsorbed with protein solutions. The wells were
washed three times with PBS, and HCjE-Gi cells were seeded
at a density of 3 × 104 cells/cm2 and incubated for 3 hours
for adhesion experiments. To investigate the population
densities, the cells were cultured for 1, 3, 5, and 7 days with
initial seeding densities of 1 × 104 cells/cm2. The cells were
fixed with 100% ice-cold methanol for 2 minutes, air dried,
and stained with DAPI for 5 minutes at RT. HCjE-Gi cells
cultured on TCP (0 μg/mL protein) were used as internal
calibration control. Images were taken with a 10× objec-
tive from five fixed positions of each well, and the number
of nuclei per view was determined to calculate the median
number of cells per square centimeter in each well. Exper-
iments were carried out three independent times, with sets
of three technical repeat wells per experiment.
Expression of Conjunctival Cell Markers
On culture day 7, the cells were fixed with 10% neutral
buffered formalin (Sigma-Aldrich) for 10 minutes at RT,
washed three times with PBS, and permeabilized with 0.2%
Triton X-100 (Sigma-Aldrich) for 15 minutes at RT. The cells
were washed three times in PBS and were incubated with
10% goat serum for 1 hour at RT. The cells were incu-
bated overnight at 4°C with rabbit monoclonal antibodies to
keratin 19 (EP15804; Abcam, Cambridge, MA, USA), rabbit
polyclonal antibodies to keratin 1 (Abcam), or mouse mono-
clonal antibodies to keratin 8 and 18 (NCL5D3; Abcam) or
to keratin 7 (SC23876; Santa Cruz Biotechnology, Heidel-
berg, Germany) diluted in 1% BSA. Following three washes
with PBS containing Tween (Sigma-Aldrich), the cells were
incubated with Alexa Fluor 594 Goat Anti-Rabbit antibod-
ies (final concentration 4 μg/mL; Life Technologies) diluted
in 1% BSA for another 1 hour at 37°C and counterstained
with DAPI. Images were taken with a 20× objective. Mouse
or rabbit immunoglobulins were used instead of the primary
antibody as an isotype control to ensure the specificity of the
antibodies. Additionally, adult retinal pigment epithelial cell
line (ARPE-19),28 corneal epithelial cell line (hTCEpi),29 or
epidermal keratinocyte cell line (HaCaT)30 were processed
alongside to confirm specificity of the primary antibodies.
All images were taken with a Nikon Eclipse Ti-E microscope
(Tokyo, Japan). The Image-Based Tool for Counting Nuclei
plug-in for Image J software (National Institutes of Health,
Bethesda, MD, USA) was used to count cells.
Statistics
All data were analyzed using Prism 6.1 software (GraphPad,
San Diego, CA, USA). One-way ANOVA with Dunnett’s multi-
ple comparison test was used to analyze the cell adhesion
experiments on pre-adsorbed proteins. Two-way ANOVA
with Tukey’s multiple comparison test was used to analyze
growth experiments across ECM preparations and upon pre-
adsorbed proteins, as well as to analyze the peptide abun-
dance of protein categories from ECM days 1 to 42. A type I
error rate of 5% was set as the threshold for statistical signif-
icance for all experiments.
RESULTS
Cell-Derived ECMs from 3-Day HCjE-Gi Cell
Cultures Supported Increased Cell Densities
Compared to ECM from 5- to 28-Day Cultures
To investigate whether the ECM from HCjE-Gi cells differed
with respect to time in culture, growth rates were deter-
mined for HCjE-Gi cells plated onto cell-derived ECMs from
days 3, 5, 7, 14, 21, and 28 in comparison with assay-
specific internal control wells on uncoated tissue culture
wells treated with ammonium hydroxide to account for any
assay-to-assay variability in cultures. Generally, the increases
in cell density of those cells cultured on each ECM prepa-
ration followed a trend similar to that of the comparator
cells cultured on TCP (Fig. 1A). However, the ECM-to-TCP
cell number ratio was almost twofold higher on the day 3
ECM, 1 day after seeding, compared to other ECM prepara-
tions, which had ECM-to-TCP cell number ratios as follows:
1.94 ± 0.17 day 3 ECM, 0.86 ± 0.14 day 5 ECM, 0.91 ± 0.13
day 7 ECM, 0.41 ± 13 day 14, 0.88 ± 0.23 day 21 ECM.
and 1.13 ± 0.40 day 28 ECM (P < 0.05 day 3 ECM vs. all
other preparations, two-way ANOVA) (Fig. 1B). After this
initial time point, ECM preparations were slightly superior to
TCP in terms of supporting increased cell densities with the
exception of day 28 ECM; however, none of the differences
between the different ECM preparations reached statistical
significance at an α of 0.05.
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FIGURE 1. Early ECM is superior to late ECM at supporting HCjE-Gi cell adhesion and expansion. HCjE-Gi cells were cultured for 3, 5, 7,
14, 21, or 28 days to obtain cell-derived ECMs. Fresh HCjE-Gi cells were then plated on top. (A) The cell density of HCjE-Gi plated onto
cell-derived ECMs (black dots/line) are compared against cells plated in parallel on TCP (red dots/line). Each dot represents one assay with
dotted line at mean. (B) The ratio of cell density on ECMs relative to TCP internal controls is plotted. Each dot represents one assay, with
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bars representing mean and standard deviation error bars. The asterisk (*) denotes significant difference (P < 0.05) compared with all other
ECMs (two-way ANOVA with Tukey’s post hoc test).
FIGURE 2. Mass spectrometry analysis of HCjE-Gi ECM preparations. (A, B) Breakdown of all peptides detected based on Unicode annota-
tions. (C) Stacked column graph of raw peptide abundance. (D) Stacked column graph displayed as percentage of peptides detected based
on Unicode annotation.
Mass Spectrometry Identified Peptides of 101
Proteins in the ECM Secreted by HCjE-Gi Cells
To identify potential reasons for the functional difference
between ECMs, the composition of the ECMs was examined
by mass spectrometry (Supplementary Data S1 file). Peptides
from 928 proteins were detected, of which 101 were iden-
tified as either ECM or ECM-associated proteins using the
Uniprot database. Of these 101 proteins, 21% were struc-
tural (collagens, glycoproteins, and proteoglycans), 24%
transmembrane (integrins and other), and 55% secreted
proteins, including GFs, GF binding proteins (GFBPs),
cytokines, proteases and inhibitors, and other secreted
proteins (Figs. 2A, 2B). As expected, the absolute number
of ECM and ECM-associated protein peptides detected
increased over time (Fig. 2C). However, as a proportion of
the peptides detected at each time point, the integrins and
the proteases and inhibitors all increased over the 42 days
in culture: integrins, 16.2 ± 0.05% day 1 and 31.4 ± 1.2%
day 42 (P < 0.001); proteases and inhibitors, 7.1 ± 0.6% day
1 and 15.1 ± 2.6% day 42 (p < 0.001) (Fig. 2D). The propor-
tion of GFs, GFBPs, and cytokines decreased: 17.5 ± 3.1%
day 1 and 4.4 ± 0.5% day 42 (P < 0.001) (Fig. 2D).
HCjE-Gi Cells Produce a Predominantly LM332
Matrix
The most abundant components—laminin (LM) α3, β3, and
γ2 and the LM332 binding integrins α6 and β4—were highly
represented at all time points (Supplementary Fig. S2),
which is consistent with most epithelial cell types31–33 and
also consistent with descriptive immunohistological findings
from intact conjunctival tissue basement membranes,34–36
including LMα3, 7.3 ± 1.1% day 1 and 13.2 ± 0.5% day
42; LMβ3, 5.6 ± 0.5% day 1 and 5.5 ± 0.8% day 42;
LMγ2, 7.4 ± 1.3% day 1 and 4.4 ± 0.5% day 42; inte-
grin α6, 7.7 ± 0.5% day 1 and 12.4 ± 0.6% day 42; and
integrin β4, 6.8 ± 0.5% day 1 and 17.6 ± 1.2% day 42
(Figs. 3A, 3B). The α5, β1, and γ1 laminin chains were all
also detected, although they were each present at less than
1% of total peptides, as were all other integrins (Fig. 3A). Of
the other laminin-binding proteins, syndecan 1 was more
abundant than syndecan 4 at all of the time points, and
thrombospondin 1 was consistently more abundant than
thrombospondin 2 (Supplementary Fig. S2). Surprisingly, the
archetypal basement membrane protein, collagen type IV,
was not detected in this dataset nor were nidogens 1 or
2. Small amounts of collagen type XVIII (0.2 ± 0.03% day
1 and 0.3 ± 0.1% day 42) and perlecan (0.6 ± 0.1% day
1 and 0.4 ± 0.1% day 42) were detected (Supplementary
Fig. S2).
GFs, GFBPs, and Cytokines Decreased and
Proteases Increased with Time
The absolute abundance of GFs, GFBPs, and cytokines
as a proportion of the total peptides is less relevant due
to their high activities at lower relative concentrations.
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FIGURE 3. HCjE-Gi cells deposit a LM332-rich matrix; however, growth factor and protease abundance change over time in culture. The
ECM preparations were processed by mass spectrometry. (A–C) The peptide abundance of the indicated protein is plotted as a proportion
of all peptides detected at the indicated time point. Each dot represents an independent biological replicate, with bars representing mean
and standard deviation error bars. (D) Stacked column graph of proteases and inhibitors as a ratio of all protease and inhibitor peptides
detected at that time point. Values are plotted as the mean of three independent experiments; error bars are omitted for clarity.
Fourteen proteins were identified as GFs, GFBPs, and
cytokines. Of these proteins, insulin was by far the most
abundant on day 1 ECM (10.9 ± 3.9%), whereas at later time
points insulin, fibroblast growth factor binding protein 1,
insulin-like growth factor binding protein 10, and transform-
ing growth factor β-induced protein ig-h3 were each present
at similar levels, with a peak at day 7 (Fig. 3C, Supplemen-
tary Fig. S2). Consistent with a decrease in growth factor
abundance, the proportion of proteases increased and the
proportion of protease inhibitors decreased over the culture
period (proteases, 39.9 ± 4.8% day 1 and 92.9 ± 1.7% day
42; inhibitors, 60.1 ± 4.8% day 1 and 7.1 ± 1.7% day 42)
(Fig. 3D). Serine protease high-temperature requirement A1
was the most abundant and displayed a steady increase over
the time course (2.2 ± 0.2% day 1 and 13.3 ± 2.6% day 42)
(Supplementary Fig. S2).
Fibronectin and α-2-HS-GP Are Enriched in Early
ECM Relative to Late ECM Preparations
Analysis of known adhesive proteins within our prepara-
tions revealed that, whereas vitronectin and nephronectin
were barely detected, fibronectin and α-2-HS-GP were
present at 0.8 ± 0.1% and 4.3 ± 0.4%, respectively, in day
1 ECM (Fig. 4A, Supplementary Fig. S1). Importantly, both
of these proteins were reduced dramatically by proportion
of total peptides in the later ECM preparations. Interestingly,
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FIGURE 4. Fibronectin and α-2-HS-GP are enriched in early ECMs and support HCjE-Gi cell adhesion and growth. (A) The peptide abundance
of fibronectin, α-2-HS-GP, and annexin A2 is plotted as a percentage of peptides detected at the indicated time points. (B) Density of HCjE-Gi
cells measured 3 hours after seeding onto indicated concentrations of fibronectin. (C) Growth curves of HCjE-Gi cells plated onto different
fibronectin concentrations. (D) Density of HCjE-Gi cells measured 3 hours after seeding onto indicated concentrations of α-2-HS-GP. (E)
growth curves of HCjE-Gi cells plated onto different α-2-HS-GP concentrations. (F) HCjE-Gi cells plated onto TCP coated with indicated
concentrations of fibronectin or α-2-HS-GP or left uncoated (TCP) were processed for indirect immunofluorescence microscopy on culture
day 7 with monoclonal antibodies against keratin 19. HCjE-Gi cells on TCP were also processed with rabbit IgG or secondary antibodies as
negative controls. Retinal pigment epithelial cells (ARPE-19) were processed in the same way as a negative control for antibodies specificity.
Scale bars: 50 μm.
the highest proportion of annexin A2, known to interact with
α-2-HS-GP and alter its functions,37 was also found in day 1
ECM (11.4 ± 1.2%) and was dramatically reduced by day 7
(1.1 ± 0.3%) (Fig. 4A). By absolute abundance, α-2-HS-GP
peaked at day 1 (2.08 × 106 ± 0.39 × 106 arbitrary units),
and fibronectin peaked at day 7 (4.92 × 106 ± 1.05 × 106
arbitrary units). These data highlighted these two proteins
as warranting further investigation.
Fibronectin Supported HCjE-Gi Cell Adhesion and
Expansion
Fibronectin has long been associated with cell adhesion
and growth of epithelial cells,32,38–41 and its detection
in our hypothesis-independent screen gave us confi-
dence in our approach. To confirm that provision of
a fibronectin at time of plating improved the adhesion
and expansion of HCjE-Gi cultures and for comparison
with α-2-HS-GP coating, we coated TCP with 0.5- to 10-
μg/mL fibronectin solutions and assessed the number of
cells adhered after 3 hours and growth curves over 7
days compared with uncoated TCP. These assays revealed
that, as expected, as fibronectin coating concentrations
increased up to a plateau of 5 μg/mL, HCjE-Gi cell adhe-
sion increased by around threefold compared with TCP
(2000 ± 260 cells/cm2 on TCP and 5300 ± 1100 cells/cm2
on 5-μg/mL fibronectin; P < 0.001) (Fig. 4B). The cell popu-
lation densities increased on all fibronectin coating concen-
trations compared with controls, with 1.26-fold higher cell
numbers on culture day 7 on 5- to 10-μg/mL fibronectin
compared to TCP (81,000 ± 22,000 cells/cm2 on TCP;
102,000 ± 8000 cells/cm2 on 5-μg/mL fibronectin; and
102,000 ± 10,000 cells/cm2 on 10-μg/mL fibronectin) (P <
0.05; two-way ANOVA).
α-2-HS-Glycoprotein Increased HCjE-Gi Cell
Growth but Not Cell Adhesion
Coating of culture plates with α-2-HS-GP from 0.5
to 20 μg/mL did not support increased cell adhesion
compared with TCP (3700 ± 500 cells/cm2 on TCP vs.
3500 ± 900 cells/cm2 on 20-μg/mL α-2-HS-GP; P > 0.05)
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(Fig. 4D); however, this coating did increase the rate at
which cell density increased in an approximately dose-
dependent manner (Fig. 4E). Specifically, when cultured on
α-2-HS-GP pre-adsorbed from 10 to 20 μg/mL, there were
1.14 to 1.18 times more cell numbers observed compared
with TCP on culture day 7 (119,000 ± 12,000 cells/cm2
on TCP; 136,000 ± 8000 cells/cm2 on 10-μg/mL α-2-HS-
GP; and 140,000 ± 6000 cells/cm2 on 20-μg/mL α-2-HS-GP)
(P < 0.01; two-way ANOVA). Processing cells for indirect
immunofluorescence microscopy with the antibodies against
conjunctival protein keratin 19, simple epithelial keratins
7, 8, and 18; corneal keratin 3; and stratified epidermal
keratin 1 revealed that culturing HCjE-Gi cells on either
fibronectin or α-2-HS-GP did not induce de- or transdiffer-
entiation (Fig. 4F, Supplementary Fig. S3).
DISCUSSION
In this study, we have shown how the composition of the
ECM secreted by HCjE-Gi cells changes over time in culture.
The ECM deposited after short periods of culture is supe-
rior at supporting the attachment and growth of conjunctival
epithelial cells compared with that deposited at later time
points. Consistent with this, mass spectrometry revealed
that early ECM consisted of higher proportions of adhe-
sive proteins including fibronectin and α-2-HS-GP, the latter
of which has not been studied in the conjunctiva before.
When provided as a substrate coating at the time of plat-
ing, both of these proteins improved the culture of HCjE-
Gi cells; fibronectin, a known adhesive protein, as expected
increased cell adhesion, and both fibronectin and α-2-HS-
GP increased the rate at which cell numbers increased in a
dose-dependent manner. Importantly, these data reveal α-2-
HS-GP as a new component that could aid the ex vivo culture
of conjunctival epithelial cells.
α-2-HS-GP is primarily produced by hepatocytes in
adults, where its production is regulated by systemic inflam-
mation.42,43 Indeed, as there are no reports of its expres-
sion in the conjunctiva or in the ocular surface, it is
unlikely we would have selected it as a candidate protein
had we not adopted a hypothesis-independent approach.
However, studies on intestinal epithelial cells and breast
carcinoma cells have shown that α-2-HS-GP does have
adhesive properties, which are mediated via annexins A2
and A6, respectively.37 α-2-HS-GP has also been shown to
increase cell migration and wound closure rates of epider-
mal keratinocyte to a level similar to that when KSF is
supplemented with bovine pituitary extract and epider-
mal growth factor.44,45 α-2-HS-GP is the human homolog
of fetuin A, which is found in fetal calf serum, one of
the many cell-adhesive proteins present in serum used in
tissue culture.42,44 In our studies, the peptide identification
(P02765) was identified as that of human origin on the
Uniprot database, thus clarifying that the protein identified
was not obtained from growth supplements used in the
culture media but rather came from cells synthesizing and
depositing their own protein into the ECM.
It is important to stress that our findings do not necessar-
ily imply that α-2-HS-GP is acting alone. Throughout the time
course, and as expected, LM332 remained the most abundant
matrix protein detected. As the cells plated onto α-2-HS-
GP or fibronectin continue to express and deposit LM332,
almost certainly synergistic effects between these proteins
are driving the change in cell behavior. Whether they each
act upon the same pathway or through distinct mechanisms
is as yet unknown but could represent a valuable avenue for
future research.
Although we have focused on adhesive proteins that
could ultimately be used for substrate modification, all of the
other data produced by the mass spectrometry experiments
represent a resource that contributes to the knowledge on
conjunctival ECMs and could be exploited to improve culture
conditions. The data specifically revealed additional interest-
ing patterns of expression of GF-related proteins, with the
highest proportion of GFs and their binding proteins being
observed in the early ECM samples. Moreover, alongside
the reduction in ECM-associated GFs in later preparations,
we observed an increase in proteases. The proteases may
cleave the GFs from the other ECM proteins, and we
cannot rule out removal of the GFs during sample prepa-
ration; however, assuming that the reduction represents
decreased production or increased turnover, these data raise
the possibility that supplementing longer term conjunctival
cell cultures with the GFs that are relatively depleted over
time may help continue cultures.
We chose to focus our studies on the widely used HCjE-
Gi cell line,46,47 as we required large cell numbers and tight
controls between replicates to reduce heterogeneity. Extend-
ing these studies into primary cultures and a wider set of
culture conditions is now a priority. Moreover, although we
have investigated α-2-HS-GP in isolation, it is likely that
a combination of substrate and culture modifications can
be identified that will further improve culture conditions.
Indeed, the aim of conjunctival cell transplantation is to
produce a functional tissue construct that is also able to
maintain goblet cells and produce mucins required for the
health of the ocular surface. Future studies are required,
therefore, to assess the growth and differentiation of goblet
cells and types of mucin production. We hope that the provi-
sion of this mass spectrometry dataset to the field will gener-
ate hypotheses that can be used for future such studies.
It should be noted that, in this study, we used NH4OH, a
hypertonic solution that disrupts the cells through osmotic
shock,48 to generate our ECM extracts. Alkaline solutions
denature proteins, solubilize cell organelles, and remove
nucleic acids48; however, the NH4OH protocol is also known
to isolate the transmembrane proteins that are associated
with the ECM proteins.25 Consistent with this, we were
able to confirm a high abundance of α6β4 integrin in our
samples. A potential drawback of using alkaline solutions
is that they have been shown to be capable of removing
glycosaminoglycans from collagenous tissues.49 Therefore,
the panel of ECM proteins we have identified may be an
incomplete measure of those deposited by conjunctival cells.
We selected to accept this potential limitation, as the func-
tional studies were performed on matrix prepared in the
same way.
CONCLUSIONS
Together, the data presented here have revealed a new candi-
date protein that could be used to enhance the growth of
conjunctival epithelial cells ex vivo and which could now
be tested for its suitability to support conjunctival cell trans-
plantation. Understanding the roles of this protein with
regard to the growth of conjunctival epithelial and goblet
cells can help the development of specific peptides from the
larger protein molecules that could be used in the surface
modification of synthetic substrates.
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